Glaxo to cut prices to poor countries
biz.yahoo.com
biz.yahoo.com
There are two problems here:
1) Affordability of drugs. The onus here is on the drug companies to be good citizens, follow Glaxo's lead, and go even further. It makes good sense for drug companies to give back in this way, like Google's support of many open-source initiatives.
2) Lack of treatment for third-world diseases. This is a much bigger problem that will require outside forces, like private foundations or government. Big drug companies are making drugs for lucrative diseases like cancer, but people in poor countries are dying of AIDS, diarrhea, or malaria, before they even have a chance of getting cancer. There's not any monetary incentive for research to go into solving these problems in poor countries.
Didn't mean to screw up the layout above. And now I can't login to edit it. Someone with magical admin powers, help me out here -- fix my comment, or let me override noprocrast so I can fix it myself.
PS there should be a character limit on the code formatting.